Heart Institute Clinical Teams Complete Training for World Hearts Levacor Next-Generation Rotary VADWorld Heart Corporation , a developer of mechanical circulatory support systems, today announced that two Canadian clinical teams have completed technical and clinical training for the use of World Hearts Levacor rotary ventricular assist device . The announcement follows the 14th November 2006 press release that the company is on a major restructuring of the economy, which allow him its activities better focus its activities is on the development of next-generation rotary VAD has begun.
‘.. Product shipment were completed in two Canadian institutions and education. Vivek Rao, cardiac surgeon and director of mechanical circulatory support Assistance, Toronto General Hospital, said: ‘Our operating team is ready, this fourth generation rotary VAD implanted We look forward to over the Levacor to circulatory disorders provide assistance to a selected group of patients on. On heart transplant other therapeutic options other therapeutic options, ‘Dr Paul Hendry, cardiac surgeon and director of mechanical circulatory assist device program at the University of Ottawa Heart Institute, added: ‘Following the success of the first clinical use of the Levacor VAD in Europe we look forward to access to this unit patients in whom conventional therapies have failed or are not suitable of 2007.n experience with these advanced, fully maglev system at the Heart Institute. Read the rest of this entry »